BUY Vodafone Idea Limited — Rajesh Palviya, Axis Securities
byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))6 May 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Vodafone Idea Limited is issuing warrants on a preferential basis, aggregating up to Rs 4,730 Crores, to Suryaja Investments Pte. Ltd.
NSE · Outcome of Board Meeting·16 May · 2d ago
1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days
Advisor consensus · same horizon·13 May · 5d ago
Board of Directors at their Meeting held on 16 May 2026, inter alia, approved the Audited Financial Results (Standalone and Consolidated) for the Financial Year ended 31 March 2026
BSE · Board Meeting·16 May · 2d ago
Vodafone Idea Ltd is seeking clarification from the exchange regarding news published on May 11, 2026.
BSE · Company Update·11 May · 1w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Vodafone Idea
- BUY — Mehul Kothari, Anand Rathi10 Oct 2026 · ~2 weeks · target ₹15 · SL hit
- BUY — Vikas Sethi, Sethi Finmart7 Oct 2026 · ~3 months · target ₹14.5 · SL hit
- BUY — Ansh Jogendra Bhilwar7 Oct 2026 · ~2 weeks · target ₹15 · SL hit
- BUY — Chandan Taparia, Motilal Oswal25 Sept 2026 · ~1 year · target ₹20 · Active
- BUY — Vikas Sethi, Sethi Finmart24 Sept 2026 · Same day · target ₹14.8 · SL hit
More from Rajesh Palviya, Axis Securities
- BUY Sansera Engineering8 Oct 2026 · ~2 weeks · target ₹4,350 · SL hit
- BUY Trent8 Oct 2026 · ~2 weeks · target ₹3,050 · SL hit
- SELL Sun Pharmaceutical Industries5 Oct 2026 · ~3 months · target ₹1,720 · SL hit
- BUY Cipla29 Sept 2026 · ~2 weeks · target ₹1,480 · SL hit
- BUY Zydus Lifesciences29 Sept 2026 · ~2 weeks · target ₹1,280 · SL hit

